Literature DB >> 8228795

Complete membranous obstruction of the inferior vena cava: clinical characteristics of Chinese patients.

P Chan1, C P Lee, C Y Yang, J S Hung.   

Abstract

OBJECTIVES: To analyse the clinical presentations of membranous-type Budd-Chiari syndrome and the long-term outcome of balloon angioplasty.
DESIGN: A case-control study. Patients who received abdominal sonography and were suspected of having hepatic venous outflow obstruction were advised to receive cardiac catheterization and angiography.
SETTING: Patients were collected from Chung Hisao Hospital and Chang Gung Medical Centre. Angioplasty was done at Chang Gung Medical Centre.
SUBJECTS: Seventeen patients who had the symptoms and signs of portal hypertension were suspected of having hepatic venous outflow obstruction after abdominal sonography and a radionuclide liver scan and eight of them were confirmed as having membranous-type obstruction.
INTERVENTIONS: Simultaneous catheterization and contrast angiography was performed via the right brachial and femoral veins. Angioplasty was performed afterwards. MAIN OUTCOME MEASURES: The remission of clinical symptoms and signs and a decrease of the pressure gradient between the right atrium and inferior vena cava were used as indicators of successful intervention.
RESULTS: All patients had remarkable remission of symptoms and signs. The average pressure gradient between right atrium and inferior vena cava dropped from 16.5 +/- 1.6 to 6.5 +/- 1 mmHg (mean +/- SD).
CONCLUSION: The clinical presentations of membranous-type Budd-Chiari syndrome are somewhat different from hepatic vein occlusion. Balloon angioplasty may be a modality for curing this disease. A larger patient population is necessary to confirm this study.

Entities:  

Mesh:

Year:  1993        PMID: 8228795     DOI: 10.1111/j.1365-2796.1993.tb00784.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  1 in total

1.  Radionuclide venography as a clue to the diagnosis of Budd-Chiari syndrome.

Authors:  E Tsukamoto; K Itoh; H Ogawa; H Shirato; N Tamaki
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.